Healthcare >> CEO Interviews >> March 20, 2003
Dr. SIDNEY PESTKA is Chairman and Chief Scientific Officer at PBL
Therapeutics. PBL Therapeutics was formed to commercialize the
ideas and utilize the expertise of Dr. Pestka, an internationally
recognized scientist with over three decades of pioneering work
in the research and development of proteins and protein
biopharmaceuticals. Dr. Pestka was the first to clone and produce
mature interferons and the first to develop a commercialized
biotherapeutic ' Roferon A ' while at the Roche Institute of
Molecular Biology of Hoffmann-La Roche, where he spent 17 years
leading these efforts. Dr. Pestka also serves as a Professor and
Chairman of the Department of Molecular Genetics, Microbiology
and Immunology at the Robert Wood Johnson Medical School of the
University of Medicine and Dentistry of New Jersey. He is
presently the named inventor on over 100 US and foreign patents
and has 400 original research articles in his name. Dr. Pestka is
a 2001 National Medal of Technology laureate. Profile
Therapeutics and what the focus is at this point?
Dr. Pestka: The origins are as follows. I became the chairman of
the
